News

Although UiPath (currently trading at $13.59 per share) has gained 5.4% over the last six months, it has trailed the S&P 500’s 11.7% return during that period. This may have investors wondering how to approach the situation.

Agentic AI software names are moving together this Friday afternoon, and the leaderboard looks like a mirror image of Monday’s session. Palantir (NASDAQ:PLTR) stock is surging 10% to $170.76 midday, while UiPath (NYSE:PATH) shares are climbing 7% to $14.93 and C3.ai (NYSE:AI) shares are rallying 5% to $10.43. The iShares Expanded Tech-Software Sector ETF (CBOE:IGV) ... Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together

UiPath (PATH) closed at $13.82 in the latest trading session, marking a -1.99% move from the prior day.

Palantir‘s (NASDAQ:PLTR) stock is ripping higher early Tuesday, with Palantir shares up 16% to $145.50 after the company posted a blowout Q2 2026 and raised its full-year outlook. The rally follows Monday’s after-close earnings release, and it hasn’t spread to peer agentic-AI names. The bounce comes off a rough stretch. Palantir stock was down 29% ... Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally

Despite a challenging first half marked by significant mark-to-market losses, Tetragon's strategic exits and strong life sciences performance provide a counterbalance to the negative returns.

UiPath (PATH) closed at $12.37 in the latest trading session, marking a -1.75% move from the prior day.

UiPath Stock Snapshot After Recent Price Move UiPath (PATH) has drawn fresh attention after a recent price move that left the stock at US$12.59 as of the most recent close. Investors are weighing this level against recent share performance and fundamentals. See our latest analysis for UiPath. Recent trading has been strong for UiPath, with a 1 month share price return of 17.88% and a 3 month share price return of 22.23%, even though the year to date share price return is down 20.72%. Over a...

UiPath stock is coming off a difficult five year stretch, with shareholders seeing the share price fall about 79.7%. However, current valuation checks now suggest the stock may be trading below its intrinsic value based on a Discounted Cash Flow (DCF) estimate. Over the past five years, UiPath has delivered a share price decline of 79.7%, which puts long term holders well under water and makes today’s pricing especially important for new and existing investors. UiPath’s ability to convert...

Marvell trades at a premium valuation with higher growth, while UiPath offers a cheaper entry point with a lower growth profile.

UiPath trades at a 15.4x forward P/E with positive net income, while Snowflake's 29% revenue growth comes at a $1.3 billion annual loss.

SNPS is among U.S. robotics plays as 2026 brings major advances in physical AI, surgical systems, defense autonomy and space robotics.

Marvell maintains a commanding revenue lead, but UiPath's latest quarter shows accelerating growth that narrows the gap.

A software firm's stock chart looks like a wreck, but its financial engine keeps humming a very different tune.

UiPath's stock has been left for dead, yet several of enterprise software's biggest players have compelling reasons to want it. Five names stand out as potential acquirers, and the logic behind one of them is almost impossible to argue against.

The robotic process automation and agentic AI specialist is a cheap growth stock that just got cheaper.

NVIDIA boasts a 55.6% net margin and $96.7 billion in free cash flow, while UiPath trades at a fraction of the valuation despite turning profitable.

This automation software firm is handing back far more cash than the average company, yet the market keeps marking it down. Here’s why.

In the latest trading session, UiPath (PATH) closed at $10.7, marking a -11.13% move from the previous day.

On July 21, 2026, investors weighed the automation software maker's agentic AI push and recent customer wins against a stock down 83% since its 2021 IPO.

UiPath's AI orchestration strategy, improving profitability and attractive valuation make it stand out over AppLovin despite both benefiting from AI adoption.

PATH's ARR increased from $1.46 billion to $1.9 billion through Q1 2027, reflecting resilient enterprise demand for AI-powered automation despite ongoing concerns over software spending.

UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Investing.com -- Cash balances of U.S. companies swelled in the first quarter of 2026, with most companies aggressively deploying money back into their businesses, according to Morgan Stanley.

Today, July 17, 2026, this week's AI pricing deal with a U.K. retailer boosted the stock as the automation provider navigates revenue headwinds.

Agentic AI is a compelling long-term opportunity.

After a steep sell-off, this profitable software company trades at a discount to the market, forcing investors to decide if the price is a gift or a warning sign.

UiPath (PATH) stock is in focus after the company signed a three year contract to build an AI driven pricing platform for UK online retailer The Very Group, adding fresh context to its automation business. See our latest analysis for UiPath. The latest Very Group contract and earlier news around buybacks and profitability come as UiPath trades at US$11.95, with a 30 day share price return of 10.75% but a 5 year total shareholder return that has declined about 81%. Recent momentum therefore...

Earlier this week, UiPath reported its first-ever quarterly GAAP operating profit and highlighted that its AI agentic products are progressing from pilot to production, while also maintaining a share repurchase program with about US$414 million still available. The company also announced a three-year agreement to build an AI-driven pricing platform for UK online retailer The Very Group, underscoring how its automation and AI tools are being applied to complex, margin-sensitive retail...

UiPath stock is trading near US$11.95 after a long stretch of weak returns, yet the valuation work suggests the market may be pricing it below what its cash flows could justify, with both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to an undervalued profile. Over the last 5 years, UiPath has delivered a share price decline of about 81.0%, which means long term holders have seen substantial value eroded even as the current valuation screens as...

The companies are helping drive increased automation in industrial applications.